Novartis Announces Positive Phase III Results for Ianalumab in Primary Immune Thrombocytopenia (ITP) Table of Contents Novartis Announces Positive Phase III Results for Ianalumab in Primary Immune Thrombocytopenia (ITP) Ianalumab …
Tag: